Vaccines for people with Lupus receiving biologics: A review

No definitive consensus about a vaccination policy for people with Lupus is currently available, so this review aims to summarise current knowledge on the influence of some current therapies and response to vaccination. Introduction Systemic lupus erythematosus (often called Lupus or shortened to SLE) is an autoimmune disease. It typically starts in women between the […]

Read More…

New: Managing SLE and SSc with non-drug options

This is the lay version of the EULAR recommendations for the non-drug management of people with systemic lupus erythematosus or systemic sclerosis – two conditions that fall under the umbrella definition of rheumatic diseases. The names are often shorted to SLE or just lupus instead of systemic lupus erythematosus, and scleroderma or SSc instead of […]

Read More…

Risk of flare higher with hydroxychloroquine reduction or discontinuation

Decisions to maintain, reduce or stop SLE treatment may affect specific subgroups differently. INTRODUCTION Systemic lupus erythematosus (often called Lupus or SLE) is an autoimmune disease. It often starts in women between the ages of 15 and 45, but it can occur at any age, and 10% of patients are male. SLE symptoms can vary. […]

Read More…

New QIs help assess and improve care in Lupus

Quality indicators can help clinics to implement the EULAR recommendations in everyday care INTRODUCTION Systemic lupus erythematosus (often called Lupus or SLE) is an autoimmune disease. It typically starts in women between the ages of 15 and 45. Lupus symptoms can vary from patient to patient. People with Lupus are often very tired, have joint […]

Read More…

Maintaining steroids for people with inactive Lupus prevents relapse

Continuing long-term low-dose prednisone may help avoid relapse in people with Lupus. Introduction Systemic lupus erythematosus (often called Lupus or SLE) is an autoimmune disease. It typically starts in women between the ages of 15 and 45. Lupus symptoms can vary from patient to patient. People with Lupus are often very tired, have joint pain, […]

Read More…

Link between fatigue and brain-reacting autoantibodies in Lupus

The presence of anti-NR2 antibodies is a helpful diagnostic tool and may offer a major new approach in managing fatigue in people with Lupus. Introduction Systemic lupus erythematosus (often called Lupus or SLE) is an autoimmune disease where immune cells in the body become hyperactive and produce autoantibodies. It typically affects women between the ages […]

Read More…

ANA status is a critical first step for diagnosing Lupus

The new classification criteria reflect current thinking about Lupus and provide an improved foundation for research. Introduction Systemic lupus erythematosus (often called Lupus or shortened to SLE) is an autoimmune disease. It typically affects women between the ages of 15 and 45, but can also start in younger children, later in life, and also in […]

Read More…